• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

JG Boswell Marches to the Beat of its Own Drummer

The real gem, the 'white whale' - or white grizzly, given recent events - has always been the company's water rights.
By JONATHAN HELLER
Jul 06, 2020 | 10:00 AM EDT
Stocks quotes in this article: BWEL, CTVA

Shares of the ever-mysterious farming and water rights giant JG Boswell (BWEL) rose 18% on Friday, putting it back near pre-Covid levels. The reason for Friday's jump was likely the sale of the company's 46% stake in Phytogen Seed Company LLC, a joint venture with Corteva (CTVA) wholly owned subsidiary Mycogen, to Corteva, the majority owner. If Corteva sounds familiar, it was a 2019 spin-off from DowDuPont.

It is not clear yet what BWEL received for the sale as details on Phytogen's financials are scant, with some information in BWEL's annual reports, which, by the way, are only available to shareholders with proof of ownership. (I literally write a letter to the company every year, with a brokerage statement proving ownership, then several weeks later I'm rewarded with the AR). I'd like to think that BWEL will reap well more than $100 million for its Phytogen stake, which is not an insignificant amount for a company with a market cap just south of $600 million, but time will tell.

BWEL is one of this value investor's greatest nemesis. I've owned shares since 2002 or so, bought on dips several times, and am still waiting for my investment thesis - the monetization of water assets - to play out. BWEL owns 150,000 or so farming acres in California, plus cotton land in Australia (more on that later), but the real gem, the "white whale" (or white grizzly, given recent events) as it were, has always been the company's water rights, estimated to at between 400,000 and 2 million acre feet. I've tended to believe the lower figure, but again, details are difficult to come by. Buyers of BWEL have long awaited the sale of those water rights; at $10,000/acre foot, that would value the water alone at $4 billion, several times the current market cap. Or at least that's the type of thinking that long-term investors have been holding onto. It's the value investor's greatest dilemma - assets on paper that appear extremely valuable - but without confirmation through monetization its just a figure on paper.

There's another potential asset sale happening at BWEL, but its been in the works for more than a year, so until it actually happens, I won't hold my breath. That's the sale of the Australian cotton farming assets, Auscott Limited, which was reported to be on the block nearly a year ago. There's still been no transaction, but talk of a $500 million+ $AD (or about $350 million $US), is again being mentioned in the Australian press, and the company website mentions that non-binding bids for the business, which includes 40,000 hectare (about 100K acres or 156 square miles, more than twice the area of Washington, DC) are due on August 12th.

BWEL is attempting to monetize some assets, just not the big enchilada (that we know of), and I wonder what the proceeds will be used for. Confusing matters is the fact that the company cut the quarterly dividend in May, from $3.75/share to $2.00. That's not the first time. BWEL also cut the dividend in 2015 from $4.50 to $2.25, and since then, had been seemingly ramping it back up.

I've seen some speculation of a "special dividend" being paid with the Phytogen proceeds, but I don't buy into that. A stock buyback may be more realistic. But again, I won't hold my breath as this company has always marched to the beat of its own drummer.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the  time of publication, Jonathan Heller was Long BWEL.

TAGS: Dividends | Economy | Investing | Stocks | Trading | Agriculture

More from Investing

Lopsided Market Returns

James "Rev Shark" DePorre
Jun 5, 2023 4:22 PM EDT

Despite the intraday reversal in Apple, Microsoft, Alphabet, Amazon, and Tesla, all helped the Nasdaq 100 outperform the other indexes as the small caps disappointed.

The Charts -- and the Data -- Support Datadog

Bruce Kamich
Jun 5, 2023 3:35 PM EDT

Here's how DDOG is emerging from a base formation.

Time for Profit-Taking on Palantir

Bruce Kamich
Jun 5, 2023 3:06 PM EDT

Here's my updated look at the charts of Palantir Technologies.

How to Trade MongoDB After Its Huge Upside Move

Bruce Kamich
Jun 5, 2023 1:45 PM EDT

Let's check out the charts and indicators for clues.

This Value Portfolio of Lovable Losers Is Down But Not Out

Jonathan Heller
Jun 5, 2023 1:10 PM EDT

With about six months to go, anything can happen for the 2023 Tax Loss Selling Recovery Portfolio.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:19 PM EDT CHRIS VERSACE

    AAP Podcast: This Company Is Not Going 'Solo'

    Listen in as I talk with the very diversified Solo...
  • 01:51 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Adjusting Your Trading Approach to Shifting Market...
  • 06:54 PM EDT CHRIS VERSACE

    AAP Podcast: A Tongue -- and a Market -- Twister: 'Get a Debt Deal Done'

    Listen in as the Action Alerts PLUS Podcast tackle...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login